Vicore Pharma News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

04.05.21	Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF (PR Newswire)
04.05.21	Vicore starts collaboration with Alex Therapeutics to develop new digital therapeutic for patients with IPF (PR Newswire)
20.04.21	Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19 (PR Newswire)
20.04.21	Vicore Pharma to host Key Opinion Leader webinar on C21 for the treatment of COVID-19 (PR Newswire)
15.04.21	Vicore Pharma publishes the Annual Report for 2020 (PR Newswire)
15.04.21	Vicore Pharma publishes the Annual Report for 2020 (PR Newswire)
11.03.21	Vicore Pharma's drug candidate C21 dilates peripheral resistance vessels in fibrotic disease (PR Newswire)
11.03.21	Vicore Pharma's drug candidate C21 dilates peripheral resistance vessels in fibrotic disease (PR Newswire)
26.02.21	Vicore Pharma Holding AB (publ) publishes the year-end report for 2020 (PR Newswire)
26.02.21	Vicore Pharma Holding AB (publ) publishes the year-end report for 2020 (PR Newswire)
09.02.21	Vicore Pharma intends to carry out a directed share issue (PR Newswire)
01.02.21	Positive data from Phase II study ATTRACT in patients with COVID-19 published online: Vicore Pharma Holding (PR Newswire)
01.02.21	Positive data from Phase II study ATTRACT in patients with COVID-19 published online: Vicore Pharma Holding (PR Newswire)
21.12.20	Positive results show that C21 can become an important complement to COVID-19 vaccines (PR Newswire)
21.12.20	Positive results show that C21 can become an important complement to COVID-19 vaccines (PR Newswire)
08.12.20	Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-19 (PR Newswire)
08.12.20	Vicore Pharma reports positive top line data from the ATTRACT clinical study in patients with COVID-19 (PR Newswire)
16.11.20	Vicore Pharma recruits the first patient in the phase II Proof-of-Concept study in idiopathic pulmonary fibrosis (PR Newswire)
06.11.20	Vicore Pharma Holding AB (publ) publishes the interim report for the third quarter 2020 (PR Newswire)
02.11.20	Vicore strengthens its pipeline with the acquisition of novel AT2R agonists and decides on an issue in kind of 142,054 shares (PR Newswire)
25.09.20	Robust effects of VP01 in human idiopathic pulmonary fibrosis lung tissue (PR Newswire)
26.08.20	Vicore Pharma Holding AB - Interim report April-June 2020 (PR Newswire)
27.07.20	Vicore Pharma doses first COVID-19 patient in the ATTRACT study in India (PR Newswire)
03.07.20	Vicore Pharma has Completed a Directed Share Issue of SEK 185 Million (PR Newswire)
02.07.20	Vicore Pharma Intends to Carry Out a Directed Share Issue (PR Newswire)
23.06.20	Vicore Pharma Expands Recruitment Base for the ATTRACT study (PR Newswire)
22.06.20	Vicore Pharma's Drug Candidate VP01 Demonstrates Potential for Significant Benefit in Severe Pulmonary Hypertension (PR Newswire)
29.05.20	LifeArc Awards £ 1.5 Million Grant to Vicore Pharma for the VP01 COVID-19 Clinical Study (PR Newswire)
22.05.19	Evotec SE (EVT-DE): Evotec expands into high-growth biologics segment (EQS Group)
17.05.19	Vicore Pharma Holding AB (VICO-SE): Key activities on track at Q1/2019 update (EQS Group)
25.04.19	Vicore Pharma Holding AB (VICO-SE): Scleroderma the second indication for VP01 (C21) (EQS Group)
26.03.19	Vicore Pharma Holding AB (VICO-SE): Pipeline on track at FY2018. Moving to IFRS (EQS Group)
13.12.18	Vicore Pharma Holding AB (VICO-SE): Funded through 2021E beyond key inflection points (EQS Group)
05.09.18	goetzpartners securities Limited: (EQS Group)
04.07.18	Vicore Pharma Holding AB (VICO-SE): Acquisition of INIM brings HealthCap on board (EQS Group)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Sonova Hldg	310.60	2.17 %	K V
Part Grp Hldg	1’249.00	1.71 %	K V
Geberit	522.60	1.16 %	K V
Novartis	92.60	1.14 %	K V
Lonza Grp	526.40	0.92 %	K V
CieFinRichemont	117.75	0.09 %	K V
UBS Group	28.13	-0.04 %	K V
Swiss Life Hldg	726.00	-0.17 %	K V
Zurich Insur Gr	546.60	-0.18 %	K V
Kuehne+Nagel Int	207.20	-0.38 %	K V

Nachrichten zu Vicore Pharma Holding AB

Aktien Top/Flop

Meistgelesene Nachrichten